Mrinmayi is an Associate Immunologist on the Immunology Team at Epitopea.

She holds an MSc in Cancer Immunology and Biotechnology from the University of Nottingham, where her research project focused on MHC-II expression in colorectal cancer.

Prior to that, she earned her BSc in Biotechnology from Fergusson College, Pune, India.

Driven by a passion for novel cancer diagnostics and immunotherapies, she is committed to making cancer treatments globally accessible, effective, and durable.